Table 3.
Abnormal measures of thrombophilia and hypofibrinolysis in 24 women who used hormone replacement therapy on estrogen-progestin oral contraceptives before pulmonary embolism (18 women had coagulation measures)
| Factor V |
PTG | Factor VIII | Factor XI |
ACLA IgG |
ACLA IgM |
Lupus anticoagulant | Pro S | Free S | Anti III | |
|---|---|---|---|---|---|---|---|---|---|---|
| Abnormal range | TC/TT | TC/TT | > 150 % | > 150 % | Dated cut pointa | Y | < 63 % | < 66 % | < 80 % | |
| ID# 1 | 78 | |||||||||
| 3 | 20.0 | |||||||||
| 4 | ||||||||||
| 5 | TC | 47 | ||||||||
| 6 | 70 | |||||||||
| 8 | TC | |||||||||
| 9 | Y | 71 | ||||||||
| 10 | 212 | |||||||||
| 11 | Y | |||||||||
| 12 | 61 | |||||||||
| 13 | 16.0 | 59 | ||||||||
| 14 | ||||||||||
| 15 | 301 | 151 | 17.0 | 39 | ||||||
| 17 | TC | |||||||||
| 18 | 48 | |||||||||
| 22 | TC | |||||||||
| 24 | TC | |||||||||
adated cut point for IgG high: ≥ 23 GPL (before 10/31/12); ≥ 15 (after 11/1/12)
dated cut point for IgM high: ≥ 10 MPL (before 4/30/12); ≥ 13 (after 5/1/12)